BioLineRx (BLRX) Revenue (2023 - 2025)
Historic Revenue for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $427000.0.
- BioLineRx's Revenue fell 9136.15% to $427000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year decrease of 4085.0%. This contributed to the annual value of $28.9 million for FY2024, which is 50291.67% up from last year.
- Per BioLineRx's latest filing, its Revenue stood at $427000.0 for Q3 2025, which was down 9136.15% from $304000.0 recorded in Q2 2025.
- In the past 5 years, BioLineRx's Revenue ranged from a high of $11.7 million in Q4 2024 and a low of $255000.0 during Q1 2025
- Over the past 3 years, BioLineRx's median Revenue value was $2.6 million (recorded in 2023), while the average stood at $3.6 million.
- In the last 5 years, BioLineRx's Revenue surged by 63948.22% in 2024 and then tumbled by 9628.01% in 2025.
- BioLineRx's Revenue (Quarter) stood at $4.3 million in 2023, then surged by 170.78% to $11.7 million in 2024, then crashed by 96.37% to $427000.0 in 2025.
- Its Revenue was $427000.0 in Q3 2025, compared to $304000.0 in Q2 2025 and $255000.0 in Q1 2025.